MGK,SOX,ORCL,NFLX,PG,TRV
Netflix (NFLX, Financial) saw its stock jump to a record high, closing up 9.7% after the company reported a significant increase in subscribers, driven by its new focus on live sports events. This surge helped lift tech stocks overall, contributing to a positive day on Wall Street.
CRISPR Therapeutics (CRSP, Financial) experienced a notable share price increase of 10% following the disclosure of investments by Robert F. Kennedy Jr., President Trump's nominee for HHS Secretary. Kennedy's holdings in CRISPR and other tech stocks like Apple (AAPL, Financial) and Amazon (AMZN, Financial) were revealed, with plans to divest within 90 days of confirmation.
Amid enthusiasm for President Trump's AI initiative, Project Stargate, tech executives voiced concerns about its execution. Google (GOOGL, Financial) announced a $1 billion investment in Anthropic, a competitor to OpenAI. Meanwhile, Nvidia (NVDA, Financial) and Arm Holdings (ARM, Financial) were named key partners, boosting their stock prices as the AI infrastructure plan gains momentum.
Santee Cooper's announcement to seek proposals for restarting nuclear reactor construction at the V.C. Summer Nuclear Station lifted nuclear-related stocks. This move aligns with tech companies' need for clean energy to support AI data centers, potentially involving firms like Amazon (AMZN, Financial) and Microsoft.
Amazon (AMZN, Financial) announced the closure of seven facilities in Quebec, resulting in job cuts. The decision, attributed to operational reviews and a shift back to third-party delivery models, affects its only unionized workforce in Canada, though Amazon denies the closures are related to unionization.
Financial sector stocks showed volatility as major banks like Citigroup (C, Financial) and JPMorgan Chase (JPM, Financial) continued to gain from positive earnings reports and expectations of business-friendly regulations under the new Trump administration.
Kinder Morgan (KMI, Financial) reported a slight miss in Q4 earnings but provided a positive outlook for 2025, with expectations of increased net income and dividends. The company plans to maintain steady growth despite missing revenue expectations for the quarter.
Moderna (MRNA, Financial) gained attention as Oracle's chairman highlighted AI's potential in developing mRNA-based cancer vaccines. This aligns with the broader AI-driven initiatives announced under Project Stargate, indicating a significant investment wave in AI technology.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.